Elysium Health Engineering Nutritional Supplements Using Science

Elysium Health Engineering Nutritional Supplements Using Science

One of the newest companies entering the supplement industry is Elysium Health. Elysium Health is a consumer health company that is looking to help people live healthier, longer by creating evidence-based dietary supplements.

Founded by a senior MIT scientist Dr. Leonard Guarente, Elysium Health takes scientific research and integrity very seriously. In order to create products that truly help people, the company conducts research with scientists from prestigious institutions like Harvard, Cambridge, and Oxford.

Dr. Guarente has himself conducted significant research on the genetic and molecular causes of aging during his career as a scientist.

Elysium Health’s product that is currently on sale is known as Basis—a supplement that increases levels of a coenzyme known as NAD+ in our cells. NAD+, scientists believe, is essential for DNA protection, circadian rhythms, and energy creation. Levels of NAD+ decline in our cells as we age, which is why Basis works to maintain high levels of the coenzyme. The idea behind Basis is based on 25 years of prior research.

Basis is clinically proven to increase levels of NAD+ by an average of 40%. It is designed to support your cellular health over long-term use. To ensure that the supplement lives up to the high standards Elysium Health puts forth, Basis undergoes independent third-party quality testing.

Elysium Health sells Basis online. You can purchase an individual bottle for $60, giving you 60 capsules of the supplement. The daily recommended dose of Basis is two capsules, so a single bottle should last 30 days. You can also purchase a subscription to Basis for between $40-50 per month, having Elysium Health send you a bottle of the supplement each month.

Elysium Health is also in the process of researching other products that focus on cognitive health, skin health, muscle function, and circadian rhythms. These are currently in various stages of pre-clinical and clinical trials.

Comments are closed.